Incidence of Epstein-Barr virus-lymphoproliferative disease by viral load following allogeneic T-cell-depleted SCT
| EBV load (gEq/mL) . | No. of patients with specified reactivation . | No. of patients with EBV-LPD . | Predictive values . | |
|---|---|---|---|---|
| Positive (%) . | Negative (%) . | |||
| 100 | 41 | 10 | 24 | 100 |
| 1 000 | 26 | 10 | 39 | 100 |
| 10 000 | 14 | 7 | 50 | 96 |
| 100 000 | 7 | 5 | 71 | 94 |
| 500 000 | 1 | 1 | 100 | 89 |
| EBV load (gEq/mL) . | No. of patients with specified reactivation . | No. of patients with EBV-LPD . | Predictive values . | |
|---|---|---|---|---|
| Positive (%) . | Negative (%) . | |||
| 100 | 41 | 10 | 24 | 100 |
| 1 000 | 26 | 10 | 39 | 100 |
| 10 000 | 14 | 7 | 50 | 96 |
| 100 000 | 7 | 5 | 71 | 94 |
| 500 000 | 1 | 1 | 100 | 89 |
gEq/mL indicates genome equivalents of EBV DNA/mL. Other abbreviations are explained in Table 1.